BA vs STRO
The Boeing Company (BA) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
The Boeing Company (BA) is a aerospace & defense company listed on NYSE. It is led by Kelly Ortberg.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported BA revenue for 2025-12-31 was $89.46B. Net income was $2.23B. Revenue was up 34.5% from 2024-12-31 to 2025-12-31. BA currently screens at market cap $177.86B and trailing P/E 89.2.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
BA currently screens at market cap $177.86B and trailing P/E 89.2. STRO currently screens at market cap $470.8M.
Not investment advice. Open the BA and STRO stock pages for the full models.
Not investment advice.